Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China
Rhea-AI Summary
Visionary Holdings (NASDAQ: GV) entered a strategic cooperation agreement with Zhejiang Chushanji Digital Technology to expand distribution of its V-series anti-aging products in China.
Chushanji operates an offline network across 5 provinces and ~10,000 stores. Visionary projects a preliminary potential annual revenue range of $10M–$15M, but notes the collaboration is at an initial stage and outcomes are uncertain due to market, execution, channel, and regulatory risks.
Positive
- Access to an offline network covering 5 provinces and ~10,000 stores
- Strategic partnership to support marketing, channel development, and sales in China
- Preliminary potential annual revenue of $10M–$15M if adoption occurs
Negative
- Cooperation is at an initial stage; timing and scale remain uncertain
- Projected revenue is subject to significant uncertainties including regulatory, market demand, and channel execution
Key Figures
Market Reality Check
Peers on Argus
GV fell 6% with elevated volume, while momentum scan shows peers like EEIQ up 74.35%, LXEH up 6.68%, and others such as GSUN and KIDZ down 6.55% and
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 09 | Exclusive agreement & exit | Positive | -16.6% | US$12M exclusive distribution deal and exit from non-core businesses. |
| Mar 05 | Growth outlook issued | Positive | -2.4% | 2026–2027 outlook with RAMU anti-aging line targeting US$30M sales. |
| Mar 02 | Huajin distribution deal | Positive | -5.1% | Exclusive Huajin agreement targeting US$12M sales and business refocus. |
| Feb 24 | US$9M contract update | Positive | -9.3% | Progress on approximately US$9M commercial sales agreement at GV Hong Kong. |
| Feb 18 | China subsidiaries setup | Positive | -1.8% | Three new China subsidiaries to expand regenerative and aesthetics products. |
Recent positive strategic and commercialization announcements have repeatedly been followed by negative 24-hour price reactions.
Over the past months, Visionary has consistently reported steps toward a pivot into high-margin medical aesthetics and healthcare. These include a US$12 million exclusive distribution agreement, a growth outlook highlighting potential US$30 million RAMU sales, and execution of a roughly US$9 million contract, along with new China subsidiaries. Despite this, each announcement saw a negative next-day move, and today’s China distribution partnership for V-series products fits that strategic commercialization trend.
Market Pulse Summary
This announcement adds another step in Visionary’s shift toward high-end medical aesthetics, pairing its V-series anti-aging products with Chushanji’s network of nearly 10,000 stores across 5 provinces and 105 markets in China. Management’s preliminary estimate of US$10–15 million in potential annual revenue remains highly uncertain and contingent on execution, demand, and regulation. Investors may track subsequent commercial milestones alongside prior distribution deals and growth targets to gauge progress.
Key Terms
forward-looking statements regulatory
AI-generated analysis. Not financial advice.
The collaboration is expected to support the Company’s commercialization efforts through access to an established offline service network
HONG KONG, March 26, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (the “Company” or “Visionary”) , a technology-driven multinational enterprise focused on biotechnology and healthcare, today announced that it has entered into a strategic cooperation agreement with Zhejiang Chushanji Digital Technology Co., Ltd. (“Chushanji”), a China-based enterprise engaged in digital marketing, brand services, and offline network operations.
According to information provided by Chushanji, the company currently operates an extensive offline commercial network spanning 5 provinces and 105 district- and county-level markets in China, covering nearly 10,000 stores.
Pursuant to the agreement, Chushanji is expected to assist Visionary in the marketing, channel development, distribution, and sales support of the Company’s V-series anti-aging products in China. By leveraging Chushanji’s existing offline business network and operational resources, the cooperation is intended to facilitate product promotion, channel penetration, and potential customer conversion across selected medical aesthetics and wellness service locations.
Chushanji has developed an offline service network through its ongoing business activities, which may provide Visionary with access to a broad base of service locations and consumer touchpoints. Through this cooperation, the Company expects to explore scalable approaches for expanding market awareness and supporting the commercialization of its V-series anti-aging products in the Chinese market.
Based on preliminary internal estimates, the Company believes that, if the collaboration progresses as expected and market adoption is achieved, annual revenue contribution from related products could potentially reach a range of approximately
Mr. Xiyong Hou, Chief Executive Officer of Visionary Holdings Inc., commented:
“This cooperation represents an important step in advancing the market rollout of our V-series anti-aging products in China. By working with a partner that has established experience in offline network operations and channel development, we aim to strengthen our product distribution capabilities, improve market access, and support our broader commercialization strategy in the medical aesthetics and wellness sector. Based on our preliminary internal assessments, we believe this cooperation may create a meaningful commercial opportunity over time, although actual results will depend on the pace of execution and market acceptance.”
The Company notes that the cooperation is currently at an initial stage, and there can be no assurance regarding the timing, scale, or financial impact of the collaboration.
About Visionary Holdings Inc.
Visionary Holdings Inc. (Nasdaq: GV) is a technology-driven multinational enterprise focused on AI applications, and high-tech healthcare solutions. Headquartered in Toronto, Canada, the Company operates through its subsidiaries across North America and Asia, driving technological advancement, cross-border innovation, and global health transformation.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook," "objective" and similar terms. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond GV's control, which may cause GV's actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to GV as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in GV's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. GV does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
Contacts:
Visionary Holdings Inc.
Investor Relations
Email: IR@visionary.holdings
FAQ
What did Visionary Holdings (NASDAQ: GV) announce on March 26, 2026 about China distribution?
How large is Chushanji's offline network supporting GV's V-series products?
What revenue could GV expect from the China cooperation with Chushanji?
What are the main risks for GV's China distribution deal announced March 26, 2026?
How will the Chushanji partnership affect Visionary Holdings' commercialization strategy for V-series?
